Citiconar-P Tablet
By Citiconar-P
Rx
10 Tablet in a Strip

Composition
Citicoline(500mg) + Piracetam(800mg)

Manufacturer - Lifecare Neuro Products Ltd
70/1 Dharampur, Sai Road, Near Export Promotion Zone Phase-II, Baddi - 173205, (Distt. Solan) Himachal Pradesh (India).

Expires on or after
September, 2025

liver
Citiconar-P Tablet is considered safe for patients with liver disease. The available data indicates that adjusting the dosage of Citiconar-P Tablet may not be necessary for individuals with liver conditions. It is recommended to consult your doctor if you have liver impairment or any related concerns before using this medication.

kidney
Citiconar-P Tablet should be used cautiously in patients with kidney disease. Dose adjustment may be necessary, especially for those with kidney impairment. It is not recommended for patients with severe kidney disease. Please consult your doctor for guidance.

alcohol
Caution Avoid alcohol with Citiconar-P Tablet Tablet as it may cause increased drowsiness. Consult your doctor.

driving
Caution should be taken when driving after taking Citiconar-P Tablet, as it may cause drowsiness, nervousness, and shakiness. These side effects could impair your focus and reaction time while driving. Avoid driving or operating machinery if affected.

pregnancy
It is better to consult your doctor before using Citiconar-P Tablet.

breastfeeding
It is better to consult your doctor before using Citiconar-P Tablet during breastfeeding, as there is no specific safety information available. Your doctor will determine if it is safe for breastfeeding mothers to take this medication.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹596
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024